Evaluation of the Analgesic Efficacy of a Bioelectronic Device in Non-Specific Chronic Low Back Pain with Neuropathic Component. A Randomized Trial
Metadatos
Afficher la notice complèteAuteur
Teresa, Carlos de; Varela López, Alfonso; Rios Álvarez, Susana; Gálvez Mateos, Rafael; Maire, Coralie; Gracia-Villar, Santos; Battino, Maurizio; Quiles Morales, José LuisEditorial
MDPI
Materia
Bioelectronics Electromagnetic signals Chronic low back pain Neuropathic pain Quality of life Functional capacity
Date
2021Referencia bibliográfica
de Teresa, C.; Varela-López, A.; Rios-Álvarez, S.; Gálvez, R.; Maire, C.; Gracia-Villar, S.; Battino, M.; Quiles, J.L. Evaluation of the Analgesic Efficacy of a Bioelectronic Device in Non-Specific Chronic Low Back Pain with Neuropathic Component. A Randomized Trial. J. Clin. Med. 2021, 10, 1781. https:// doi.org/10.3390/jcm10081781
Résumé
Low energy pulsed electromagnetic signals (PEMS) therapy, in the field of bioelectronics,
has been suggested as a promising analgesic therapy with special interest in treating conditions
with poor response to pharmacotherapy. This study evaluated the effectiveness of PEMS therapy
on the treatment of chronic low back pain patients with a neuropathic component. A group of
64 individuals with such condition was allocated to a 2-week treatment period (10 twenty-minute
sessions on consecutive days) with an active PEMS therapy device or an inactive device in random
order. The pain was assessed on a visual analog scale, and the functional status was assessed using
the SF-12 questionnaire. The visual analog scale scores were lower after treatment than at baseline
but only in the group treated with the active device. According to the DN4 score, neuropathic pain
decreased in both experimental groups with respect to baseline, but this was only significant for the
group treated with the active device. Similarly, an improvement in the SF-12 and Medical Outcomes
Study (MOS) sleep scale components was reported. The study demonstrated that low-energy PEMS
therapy was efficient in reducing pain and improving function in chronic low back pain patients with
a neuropathic component.